Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Filings indexed 913 across all filing types
Latest filing 2022-03-07 Capital/Financing Update
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Marketing, Operational & Revenue Update 3 pages 390.5KB
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement dated 8 March 2022 from ECS Botanics Holdings Ltd. It discusses the company's expected revenue growth for the current quarter, appointment of a new production manager, marketing initiatives, and management commentary. The content focuses on operational updates, quarterly revenue expectations, and strategic appointments rather than presenting full financial statements or detailed financial analysis. The document length is 7,225 characters, which is relatively short and typical for a market announcement rather than a comprehensive financial report. There is no indication that this is a full quarterly or interim report containing substantive financial data, nor is it a simple notice of report publication. The document is primarily an update on quarterly performance and company developments, consistent with a Capital/Financing Update or operational update. Given the focus on quarterly revenue growth and operational updates, the most appropriate classification is Capital/Financing Update (CAP).
2022-03-07 English
Half Yearly Report and Accounts 24 pages 798.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4D' and is for ECS Botanics Holdings Limited, presenting results for the half-year ended 31 December 2021. It includes detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, and Notes to the Financial Statements. It also contains a Directors' Report, Auditor's Independence Declaration, and an Independent Auditor’s Review Report. The document covers operational review, financial results, and events after the reporting date. The presence of comprehensive financial data and the half-year period indicates this is an Interim / Quarterly Report. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is 'IR' (Interim / Quarterly Report). H1 2022
2022-02-22 English
HY Report - Increasing Sales Drives Revenue Growth 2 pages 359.4KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 23 February 2022 from ECS Botanics Holdings Ltd. It provides a detailed financial update for the half year ended 31 December 2021 (H1 FY2022), including revenue figures, loss after tax, cash balance, assets, and management commentary. The content includes substantive financial data and analysis for a period shorter than a full fiscal year, which aligns with the definition of an Interim / Quarterly Report (IR). The document is 4467 characters long, which is sufficient to contain detailed financial information rather than just an announcement or summary. There is no indication that this is a full Annual Report (10-K) or just a brief earnings release (ER). Therefore, the classification is Interim / Quarterly Report (IR). H1 2022
2022-02-22 English
ECS delivers first shipment to the United Kingdom 2 pages 353.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 February 2022 from ECS Botanics Holdings Ltd. It reports the company's first shipment of dried cannabis flower to the UK, including details about purchase orders, market expectations, and statements from company executives. The content focuses on a business update regarding international export and market expansion, without any financial statements, regulatory certifications, or detailed financial data. The document length is 4012 characters, which is relatively short and reads like a press release or business update rather than a formal financial report or regulatory filing. There is no indication that this is an earnings release, annual or interim report, or any other formal financial document. It is also not a report publication announcement or certification. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements and business updates that do not fit other specific categories.
2022-02-13 English
Change in substantial holding 2 pages 86.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder in ECS Botanics Holding Ltd. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2022-02-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 557.2KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'December 2021 Quarterly Activities Report' and provides detailed financial and operational data for the quarter ended 31 December 2021. It includes revenue figures, cash flow statements, operational updates, corporate developments, and management commentary. The presence of actual financial data such as receipts from customers, revenue, net cash used in operations, and cash flow statements confirms it is a substantive financial report for a period shorter than a full fiscal year. The document also includes an Appendix 4C cash flow report, which is a regulatory requirement for quarterly reporting in Australia. The detailed financial and operational content aligns with the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a brief summary, nor is it a full annual report or earnings release. Therefore, the correct classification is IR with high confidence. Q2 2022
2022-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.